Protara Therapeu Rg
Clinical‑stage biopharma in New York, Protara Therapeutics develops TARA‑002 cell therapy in Phase II for bladder cancer & lymphatic malformations, plus IV choline chloride for parenteral nutrition.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 28
- HQ: New York
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.